1. 433PAn open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors. (23rd October 2018) Authors: Palshof, J A; Kümler, I; Sørensen, P G; Jensen, B V; Nielsen, D L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗